Contractor
Bristol-Myers Squibb spol. s r.o.
CZE / Praha - Michle / 14000
Total awarded
€68.3M
Award notices won
13
Lots won
14
Last award
Aug 06, 2026
Awarded lots
| Lot | CPV | Contract nature | Award value | Estimated value | Place | Award criteria |
|---|---|---|---|---|---|---|
LOT-0001 / Dodávky léčivého přípravku s obsahem léčivé látky NIVOLUMAB | Antineoplastic agents | supplies | €21.9M | €21.9M | CZE | price / 100% |
LOT-0002 / Cytostatikum s obsahem účinné látky nivolumab | Antineoplastic agents | supplies | €16.9M | €8.72M | CZE | price / 100% |
LOT-0001 / Selektivní imunosupresiva - Belatacept II. | Immunosuppressive agents | supplies | €6.04M | €6.04M | CZE | price / 100% |
LOT-0002 / L01FF01 NIVOLUMAB | Pharmaceutical products | supplies | €3.2M | €3.2M | CZE | price / 100% |
LOT-0001 / Cytostatikum s obsahem účinné látky ipilimumab | Antineoplastic agents | supplies | €2.99M | €1.86M | CZE | price / 100% |
LOT-0001 / Kardiaka 12 - Mavakamten | Cardiac therapy medicinal products | supplies | €2.71M | €2.71M | CZE | price / 100% |
LOT-0002 / Část 2 | Cardiac therapy medicinal products | supplies | €2.57M | €2.57M | CZE | price / 100% |
LOT-0001 / Dodávky léků – ORENCIA 2024 | Antineoplastic and immunomodulating agents | supplies | €2.2M | €2.2M | CZE | price / 100% |
LOT-0001 / Léčivé přípravky s obsahem účinné látky Ipilimumab | Various medicinal products | supplies | €2.08M | €1.94M | CZE | price / 100% |
LOT-0001 / DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ - Květen_14/2026 - MAVAKAMTEN | Medicinal products for the cardiovascular system | supplies | €1.88M | €1.21M | CZE | price / 100% |
Show 4 more rows
LOT-0003 / Léčiva pro NEMCB (052026) Část 3 - L01FY02 NIVOLUMAB A RELATLIMAB | Medical preparations excluding dental consumables | supplies | €1.76M | €570,251 | CZE | price / 100% |
LOT-0003 / Léčiva pro NEMCB (052026) Část 3 - L01FY02 NIVOLUMAB A RELATLIMAB | Medical preparations excluding dental consumables | supplies | €1.76M | €569,593 | CZE | price / 100% |
LOT-0001 / Selektivní imunosupresiva - Belatacept | Immunosuppressive agents | supplies | €1.59M | €1.59M | CZE | price / 100% |
LOT-0001 / FN Motol – Nivolumab | Antineoplastic agents | supplies | €770,691 | €405,629 | CZE | price / 100% |
Award tenders
| Tender | Buyer | Publication date | Procedure | Award date | Awarded to contractor | Lots won |
|---|---|---|---|---|---|---|
| DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ 547899-2026 | Všeobecná fakultní nemocnice v Praze | Aug 06, 2026 | restricted | Jul 26, 2026 | €1.88M | 1 |
| Dodávky léčivého přípravku s obsahem léčivé látky NIVOLUMAB 521547-2026 | Fakultní nemocnice Motol a Homolka | Jul 27, 2026 | neg-wo-call | Jul 26, 2026 | €21.9M | 1 |
| Léčivé přípravky s obsahem alprostadilu, mavakamtenu 514814-2026 | Fakultní nemocnice Hradec Králové | Jul 23, 2026 | open | Jul 20, 2026 | €2.62M | 1 |
| L01FF01 NIVOLUMAB 484140-2026 | Fakultní nemocnice u sv. Anny v Brně | Jul 13, 2026 | oth-single | Jul 12, 2026 | €3.2M | 1 |
| Kardiaka 12 - Mavakamten 498633-2026 | Institut klinické a experimentální medicíny | Jul 19, 2026 | open | Jul 09, 2026 | €2.71M | 1 |
| Léčiva pro NEMCB (052026) 489509-2026 | Nemocnice České Budějovice, a.s. | Jul 14, 2026 | open | Jul 02, 2026 | €3.97M | 1 |
| Selektivní imunosupresiva - Belatacept II. 448790-2026 | Institut klinické a experimentální medicíny | Jun 29, 2026 | open | Jun 25, 2026 | €6.04M | 1 |
| Léčiva pro NEMCB (052026) 450375-2026 | Nemocnice České Budějovice, a.s. | Jun 30, 2026 | open | Jun 10, 2026 | €3.49M | 1 |
| Léčivé přípravky s obsahem účinné látky Ipilimumab 469143-2024 | Krajská nemocnice Liberec, a.s. | Aug 04, 2024 | open | Jul 28, 2024 | €2.08M | 1 |
| FN Motol – Nivolumab 472056-2024 | Fakultní nemocnice Motol a Homolka | Aug 05, 2024 | open | Jul 21, 2024 | €770,691 | 1 |
Show 3 more rows
| Selektivní imunosupresiva - Belatacept 345084-2024 | Institut klinické a experimentální medicíny | Jun 11, 2024 | open | May 13, 2024 | €1.59M | 1 |
| Cytostatika 2024 247785-2024 | Fakultní nemocnice Plzeň | Apr 25, 2024 | open | Apr 22, 2024 | €20.1M | 2 |
| Dodávky léků – ORENCIA 2024 176730-2024 | Revmatologický ústav | Mar 25, 2024 | open | Mar 17, 2024 | €2.2M | 1 |
Company details
Identifiers
43004351
Countries
CZE
Cities
Praha - Michle
Post codes
14000
Emails
CPV codes
Size
large
Listed
false
About this contractor
Bristol-Myers Squibb spol. s r.o. is a contractor that has been awarded public procurement contracts published through official European procurement systems.
This profile summarizes publicly available procurement information, including awarded contract value, awarded lots, procurement history, countries of activity, CPV classifications, and recent contract awards.
FAQ
What information does this contractor profile contain?
This profile summarizes publicly available procurement information about the contractor, including awarded contract values, awarded lots, procurement history, CPV classifications, locations, and company details when available.
What does Total Awarded mean?
Total Awarded represents the total known value of awarded contracts associated with this contractor based on available procurement data.
Why can the awarded value differ from the total contract value?
A contractor may be awarded one or more lots within a procurement procedure. As a result, the contractor's awarded value may differ from the total value of the procurement notice.
What are Awarded Lots?
Awarded lots are individual parts of a procurement procedure that have been awarded to this contractor.
How often is this profile updated?
Contractor profiles are updated automatically when new procurement notices and contract award notices become available.
Why are some company details missing?
Contractor profiles are generated from publicly available procurement notices. Some information, such as contact details or company registration data, may not be available in every notice.
Understanding this contractor profile
This contractor profile is generated from publicly available procurement information published by contracting authorities.
The profile helps procurement professionals, suppliers, researchers, and journalists understand a contractor's participation in public procurement.
Information may include awarded contract values, awarded lots, procurement history, procurement categories (CPV), locations, and contracting authorities.